Stay updated on Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.

Latest updates to the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label was updated from Revision: v3.6.4 to Revision: v3.6.5, and certain related topics were removed from the footer (Type 2 diabetes and MedlinePlus Genetics).SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page displays a new site revision label (Revision: v3.6.4) in place of the previous revision, indicating a backend/UI update without changing the study information.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, indicating a minor backend/frontend update. No substantive study details were changed.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.6.2 appears instead of v3.6.0, signaling a software version update rather than a change to study data.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Type 2 diabetes and MedlinePlus Genetics under the Related topics section, expanding contextual links to diabetes-related resources for this study.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows that recruitment has ended and adds several help/how-to sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting and removes some related topics.SummaryDifference0.6%

Stay in the know with updates to Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tesofensine/Metoprolol in Type 2 Diabetes Clinical Trial page.